Skip to content

Evaluating the Feasibility of Point of Care Birth Testing in Eswatini

Evaluating the Feasibility of Point of Care Birth Testing in Eswatini

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04206878
Enrollment
3316
Registered
2019-12-20
Start date
2017-06-01
Completion date
2020-12-31
Last updated
2021-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS, HIV Infections, Infant Morbidity, Neonatal Infection, Pediatric HIV Infection, Transmission, Perinatal Infection

Keywords

HIV, POC, EID, Pediatrics

Brief summary

This study aims to assess the feasibility and utility of birth testing using point-of-care (POC) testing in maternity settings in Eswatini.

Detailed description

This UNITAID-funded study aims to assess feasibility and utility of birth testing, \[early infant diagnosis for HIV, (EID)\], using point-of-care (POC) HIV nucleic acid testing (NAT) at high volume maternity settings. Birth testing is defined as tests within 3 days of life. Outcome measures will include age at testing, turnaround time from testing to caregiver result receipt, HIV positivity rate, and timing of anti-retroviral therapy (ART) initiation for HIV-positive infants. The study will document retention in care for those who tested positive at birth, and the percent of those who tested negative at birth who returned for six week testing. The study will also assess the feasibility and acceptability of POC birth testing using interviews with policymakers, health care workers and caregivers of HIV-exposed infants (HEI).

Interventions

DIAGNOSTIC_TESTPoint-of-care birth test

Collect quantitative data through clinical chart and form abstractions; collect qualitative data through in-depth interviews with caregivers, health workers and policymakers

Sponsors

UNITAID
CollaboratorOTHER
Elizabeth Glaser Pediatric AIDS Foundation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 4 Days

Inclusion criteria

* HIV Exposed Infants * Must have been newly born at the study sites or presenting in study sites within 3 days after birth * Tested for HIV using POC EID platform (mother or caregiver agreed to have infant tested) * Health Care Workers (HCWs) * HCWs who have used POC EID for at least three months, at project sites * HCWs that work directly with POC EID services at maternity providing clinical services or operating the platform * HCWs who consent to be interviewed * HCWs able to speak one of the study languages * Laboratory Managers and program leads/focal persons: * National or regional level manager or head of department whose responsibilities include EID * Member of a national technical working group or advisory board member working on EID * National level representative from the MOH * Laboratory managers in the 3 study sites * Participants 18 years and above who consent to be interviewed * Mothers/caregivers: * Mother/caregiver of an HEI who was offered POC EID at birth * Provides consent to participate in the study * Is 18 years or older, or is less than 18 years old but is legally married (and thus legally emancipated) * Speaks one of the study languages

Exclusion criteria

* HEIs: * HEI tested for HIV using conventional EID at projects sites * HEI whose caregivers refuse birth testing * HEI where the clinician deems there is a contra-indication for sample collection for birth testing (e.g. severe hemophilia) * HCWs: * HCWs who work within project sites that do not make use of EID (i.e. HCWs who are not involved directly with EID) * HCWs working in non-project sites * HCWs who are unable to consent or do not speak a study language * Laboratory Managers and program leads/focal persons: * Inability to give consent * Inability to speak study language * Mothers/Caregivers: * Not eligible for POC birth testing services * Not able to consent * Does not speak English or SiSwati

Design outcomes

Primary

MeasureTime frameDescription
Percent of eligible HEI born at or presenting to pilot facilities who receive POC EID testing at birth24 monthsNumber of eligible HEI born at or presenting to pilot facilities receiving POC EID testing as a proportion of the number of HEI born or presenting to pilot facilities

Secondary

MeasureTime frameDescription
HIV positivity rate among HEI tested at birth24 monthsNumber of HEI testing HIV positive at birth as a proportion of the number of HEI tested at birth
Number of HIV-infected infants (HII) tested at birth who are started on ART within 2 weeks of the birth test24 monthsNumber of HII tested at birth started on ART within 2 weeks as a proportion of the number of HII tested at birth
Percent of tested HEI whose caregivers receive results of the POC EID birth testing24 monthsNumber of tested HEI whose caregivers receive results of the POC EID birth testing as a proportion of the number of tested HEI
Percent of HEI who test HIV negative at birth and who test positive at 6-8 weeks24 monthsNumber of HEI who test HIV negative at birth and who test HIV positive at 6-8 weeks as a proportion of the number of HEI who test HIV negative at birth
Percent of HII testing HIV positive at birth or at 6-8 weeks in care for the first 3 and/or 6 months of life24 monthsThe number of HII testing HIV positive at birth or at 6-8 weeks in care for the first and/or 6 months of life as a proportion of the number of HII testing HIV positive at birth or at 6-8 week of life
Percent of HEI testing HIV negative at birth who return for testing at 6-8 weeks24 monthsNumber of HEI testing HIV negative at birth who return for testing at 6-8 weeks as a proportion of the number of HEI testing HIV negative at birth

Countries

Eswatini

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026